Coneview

Pfizer (PFE) price forecast

Pfizer is trading at 25.15. Over the next 4 hours our simulation puts it between 24.83 and 25.54— that's the 10th-to-90th percentile of 20,000 modelled outcomes, so roughly four times in five it should land inside that band. The model puts the odds of finishing higher at 55%. These are probabilities, not predictions of certainty, and the backtest below shows exactly how often the model has been right.

Price history & forecast cone — 10th–90th percentile of 20,000 simulated futures

25.4625.1824.9124.63NOW+4H · 12:34 PMP90 25.54 · 90th pctP10 24.83 · 10th pct

Pfizer forecast by timeframe

TimeframeLikely rangeMidpointOdds higher
5 Minutes25.1025.2125.1551%
15 Minutes25.0625.2525.1551%
1 Hour24.9825.3425.1652%
4 Hours24.8325.5425.1855%
30 MinutesAvailable on Pro →
1 DayAvailable on Pro →
1 WeekAvailable on Pro →
1 MonthAvailable on Pro →
6 MonthsAvailable on Pro →
1 YearAvailable on Pro →
5 YearsAvailable on Pro →

Intraday horizons are free. Longer horizons — 1 day through 5 years — are part of Pro.

How accurate has this model been on Pfizer?

Every forecast site claims accuracy. Here is ours, measured by walk-forward backtest on data the model never saw during training. Where it has no edge over a naive baseline, we say so.

HorizonDirectional accuracyBaselineEdgeVerdict
1-day49.0%51.6%-2.6%no edge
7-day48.6%50.3%-1.7%no edge
30-day54.3%52.2%+2.1%has edge

Backtested on 1925unseen samples. "No edge" means the model was no better than assuming the recent trend continues — an honest result, and a common one.

What the model is saying about Pfizer

The model sees PFE, currently near 25.15, holding roughly flat across every horizon. Over one week it expects about 25.14 (range 24.07 to 26.26) with a near-coin-flip 50.8% chance of rising. The one-month view centers on 25.09 (23.98 to 27.41, prob up 46.2%), and the one-year view drifts to 24.65 with a wide 18.10 to 33.60 band and 46.7% odds up. Confidence is labeled moderate at one week and degrades to low and very low further out. Annualised volatility of 23.96% explains those widening ranges, while trailing-month momentum was positive at 6.05%. On edge, be blunt: the ML model fails to beat the naive baseline at one day (49.0% vs 51.6%) and one week (48.6% vs 50.3%), and only narrowly clears it at 30 days (54.3% vs 52.2%). Sustained moves beyond the stated ranges, a volatility shift, or momentum reversal would undermine these largely flat, low-conviction projections.

How to read this forecast

We don't publish a single price target, because nobody can know one. Instead the engine runs 20,000 simulated futures for Pfizer and reports the band containing the middle 80% of them — the 10th to 90th percentile. A wide band means genuine uncertainty; a narrow one means the recent range has been calm. The odds higher figure is a calibrated probability: when we say 60%, outcomes of that kind should finish higher about 60 times in 100. Near 50% there is no directional signal at all, and the range itself is the entire forecast.

More depth: what a forecast cone is, how to read a P10–P90 range, and what makes a probability trustworthy. Our public accuracy scorecard shows where the model has an edge — and where it has none.

See the live Pfizer forecast

Streaming prices, an interactive cone across every timeframe, and the full honesty scorecard.

Open Pfizer in Coneview →

Other stock forecasts

AppleMicrosoftNVIDIATeslaAmazonAlphabetMeta PlatformsNetflixAMDIntel

Forecasts are probabilistic estimates from historical price data, not financial advice. Short-horizon direction has only a small measurable edge; long-horizon numbers reflect drift plus widening uncertainty and should be read as ranges, not targets. Figures update hourly. Coneview provides statistical market information, not financial advice.